Department of Obstetrics, Center of Fetal Medicine and Pregnancy, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Ultrasound Obstet Gynecol. 2023 Jan;61(1):40-48. doi: 10.1002/uog.26075.
To estimate the prevalence of chromosomal conditions in all fetuses and children with major congenital heart defect (CHD) in Denmark between 2008 and 2018.
This was a national registry-based study including all singleton pregnancies with a prenatally or postnatally diagnosed major CHD usually requiring surgery within the first year after birth and a due date between July 2008 and December 2018 in Denmark. Data were retrieved from the Danish Fetal Medicine Database (DFMD) and the Danish Cytogenetic Central Register (DCCR) in October 2020. The DCCR contains information on all prenatal and postnatal genetic analyses, including karyotyping, chromosomal microarray, polymerase chain reaction, multiplex ligation-dependent probe amplification and fluorescence in-situ hybridization. All cases were reviewed by a clinical geneticist, and genetic changes were classified as pathogenic, likely pathogenic, variant of uncertain significance, likely benign or benign. Pathogenic and likely pathogenic variants were considered to be abnormal. Cases with CHD without any registered chromosomal analysis reported were considered genetically normal. Isolated CHD was defined as a case with major CHD without any other structural malformations detected prenatally or postnatally. Results are given as n (%). Comparisons between isolated and non-isolated cases were performed using logistic regression analysis, and data are presented as odds ratios (ORs) with 95% CIs.
A total of 8482 cases with any cardiovascular diagnosis were retrieved from the DFMD. Twins (n = 112) and minor CHD cases (n = 6921) were excluded, resulting in 1449 cases with major CHD. Of the included cases, 918 (63.4%) underwent chromosomal analysis. An abnormal test result was found in 187 cases, giving a prevalence of a chromosomal condition of 12.9% (95% CI, 11.2-14.7%) among all cases with major CHD. The highest prevalence of a chromosomal condition was found in cases with pulmonary atresia with intact ventricular septum and those with truncus arteriosus (both 28.6%), while the lowest prevalence was found in cases with transposition of the great arteries (2.2%) and congenitally corrected transposition of the great arteries (0%). In isolated cases of transposition of the great arteries, the prevalence of a chromosomal condition was 0.6%. The overall OR for a chromosomal condition in non-isolated cases compared with isolated cases was 2.72 (95% CI, 1.90-3.88).
We found an overall prevalence of a chromosomal condition of 12.9% among cases with major CHD in a national cohort with a high participation rate in first- and second-trimester screening, without employing whole genome and whole exome sequencing. The prevalence of a chromosomal condition varied considerably according to CHD diagnosis and presence of associated extracardiac malformations. These findings are important for prenatal counseling. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
评估 2008 年至 2018 年丹麦所有患有重大先天性心脏病(CHD)的胎儿和儿童的染色体疾病患病率。
这是一项基于全国登记的研究,纳入了所有在丹麦妊娠 2008 年 7 月至 2018 年 12 月期间,经产前或产后诊断患有通常需要在出生后一年内进行手术的重大 CHD 的单胎妊娠,以及有相应预产期的妊娠。数据来自丹麦胎儿医学数据库(DFMD)和丹麦细胞遗传学中央登记处(DCCR)。DCCR 包含所有产前和产后遗传分析的信息,包括核型分析、染色体微阵列分析、聚合酶链反应、多重连接依赖性探针扩增和荧光原位杂交。所有病例均由临床遗传学家进行复查,并将遗传变化分类为致病性、可能致病性、意义不明的变异体、可能良性或良性。致病性和可能致病性变异体被认为是异常的。没有报告任何染色体分析的 CHD 病例被认为是遗传正常的。孤立性 CHD 定义为产前或产后未发现任何其他结构畸形的重大 CHD 病例。结果以 n(%)表示。采用逻辑回归分析比较孤立性和非孤立性病例,数据以比值比(OR)和 95%可信区间(CI)表示。
DFMD 共检索到 8482 例任何心血管诊断病例。排除了双胞胎(n=112)和轻微 CHD 病例(n=6921),最终纳入 1449 例重大 CHD 病例。纳入的病例中有 918 例(63.4%)进行了染色体分析。187 例检测结果异常,重大 CHD 病例中染色体疾病的患病率为 12.9%(95%CI,11.2-14.7%)。在肺动脉闭锁伴完整室间隔和动脉干畸形的病例中,染色体疾病的患病率最高(均为 28.6%),而在大动脉转位和矫正性大动脉转位的病例中,患病率最低(均为 2.2%)。大动脉转位的孤立性病例中,染色体疾病的患病率为 0.6%。非孤立性病例与孤立性病例相比,染色体疾病的总体 OR 为 2.72(95%CI,1.90-3.88)。
我们在一个高比例孕妇参加了一、二阶段筛查的全国队列中发现,患有重大 CHD 的病例中,染色体疾病的总体患病率为 12.9%,而未采用全基因组和全外显子测序。染色体疾病的患病率根据 CHD 诊断和伴发的心脏外畸形而有很大差异。这些发现对产前咨询很重要。© 2022 作者。超声在妇产科由约翰威立父子有限公司出版代表国际妇产科超声学会。